Skip to main content
Advertisement
Home

Main navigation

  • Digital Issue Archive
  • Service Directory
  • Awards
  • Advertise
  • Subscribe now

Secondary

  • Travel Insurance
  • Policies & Partnerships
  • Travel Risk Management
  • Travel Trends
  • Hospitals & Healthcare
  • Industry Moves
  • Reviews
International Hospitals & Healthcare Part of the IH&H family
Part of the
IH&H family
International Hospitals & Healthcare

Rwanda reports Marburg virus outbreak

Travel Trends
1 Oct 2024 | Oliver Cuenca
Share
Marburg virus

Rwandan health authorities have confirmed that eight people have died due to an outbreak of Marburg virus in the country

The Rwandan government declared an outbreak of the dangerous haemorrhagic fever virus on 27 September.

So far, there have been 26 confirmed cases, including eight deaths, spread across seven of the country’s 30 districts. Over 70% of the cases are healthcare workers employed at two health facilities in Kigali.

The districts with cases are Gasabo, Gatsibo, Kamonyi, Kicukiro, Nyagatare, Nyarugenge and Rubavu.

As a result, the World Health Organization (WHO) is now mobilising expertise and outbreak response tools, including emergency medical supplies, to control the virus.

Contact tracing is currently underway in Rwanda, with 300 people under follow-up as of 29 September, according to the WHO. One of the contacts has travelled internationally, but remained healthy and completed their monitoring period without presenting symptoms.

Additionally, the WHO said that it is “coordinating efforts to reinforce collaborative cross-border measures for readiness and response”, with the aim of ensuring timely detection and control of the virus in neighbouring countries.

Symptoms can be severe, and potentially fatal

The virus, which is closely related to Ebola, originates in fruit bats, and is spread through close physical contact with infected individuals or surfaces they have been in contact with, such as bed sheets.

Symptoms of the virus can take days to manifest, and can include muscle pain, fever, diarrhoea, vomiting, and, in some cases, potentially fatal haemorrhaging of blood.

As well as being highly contagious, there is currently no authorised vaccine or treatment for the disease, which has a fatality rate of up to 88%. The WHO noted, however, that there are “several promising candidate medical countermeasures”.

The Rwandan public have been advised to avoid close contact with others to reduce the spread of the virus.

The WHO also recently confirmed “significant progress” in negotiations for a new global agreement outlining how future pandemics will be managed.

Travel Trends
1 Oct 2024
Share

Oliver Cuenca

Oliver Cuenca is a Junior Editor for Voyageur Group, joining in 2021. He writes for both ITIJ and AirMed&Rescue, covering a range of topics including international travel and health insurance, medical assistance provision and air medical transportation. He also serves as Title Editor of the Assistance & Repatriation Reviews. Oliver holds an MA in Magazine Journalism from Cardiff University, as well as a BA in English with Creative Writing from Falmouth University.

Keep on reading

No results

There are no results available matching your search term.

Why subscribe to ITIJ?

In-depth analysis

In-depth analysis

Unique insights and expert opinions on the latest industry developments

A wider perspective

A wider perspective

Get the global view on the topics that are trending in your region

Breaking news

Breaking news

ITIJ.com has all the latest news relevant to travel insurance and IPMI professionals

Subscribe now
ITIJ IH&H

Footer menu

  • About Us
  • Subscribe
  • Advertise
  • Contact
  • Privacy Policy
  • Terms
  • Voyageur
International Travel & Health Insurance Conferences

Social

  • LinkedIn link
  • Twitter link

© Voyageur Publishing & Events 2026

Close